Target intelligence / Profile preview

Epidermal keratinocyte plasma membrane

Molecular classification
Other
01

Overview

The epidermal keratinocyte plasma membrane is the fundamental lipid bilayer that encloses keratinocytes, the primary cells of the skin's epidermal layer. It serves as a critical interface for cell-cell communication and provides the structural foundation for the skin's barrier function through specialized junctions like desmosomes and adherens junctions [PMID: 25611318]. This membrane is not a single molecular target but rather a complex cellular structure containing numerous proteins, including receptors like the Epidermal Growth Factor Receptor (EGFR) and various cytokine receptors that are key therapeutic targets in inflammatory and neoplastic skin diseases [PMID: 30245213]. In conditions such as atopic dermatitis and psoriasis, the integrity and composition of the keratinocyte membrane and its associated lipid matrix are often compromised, leading to impaired barrier function and chronic inflammation [PMID: 29355414]. Consequently, while drugs may interact with specific components of the membrane, the membrane itself is viewed as a structural component of the integumentary system rather than a discrete pharmacological target. Therapeutic interventions often aim to restore the barrier properties of this membrane or modulate the signaling of the proteins embedded within it to treat dermatological disorders.

Other names
Keratinocyte cell membraneKeratinocyte surface membraneKeratinocyte bilayer
02

Mechanism of action

Drugs typically target specific receptors (e.g., EGFR), enzymes, or ion channels located on or within this membrane structure rather than the membrane itself.

03

Biological functions

Physical barrierCell-cell adhesionSignal transductionSelective permeabilityLipid metabolism
04

Disease associations

PsoriasisAtopic dermatitisPemphigus vulgarisSkin cancerIchthyosis
05

Safety considerations

Skin barrier disruptionIncreased transepidermal water lossContact dermatitisPhotosensitivity
06

Interacting drugs

Cetuximab

3 more in the full profile.

07

Biomarkers

Transepidermal water loss (TEWL)Filaggrin expression levelsLoricrin expression levels

Beyond the preview

Go deeper on Epidermal keratinocyte plasma membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epidermal keratinocyte plasma membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call